Roth MKM raised the firm’s price target on Imax to $23 from $22 and keeps a Buy rating on the shares. The firm remains positive on the company for its blockbuster focus, global footprint, and asset light business model, also raising its Q2 estimates due to the outperformance of Inside Out 2 and believes that Imax remains on track to achieve over $1B of global box office in 2024, the analyst tells investors in a research note. Q3 also has a deep lineup of titles, highlighted by the upcoming Deadpool and Wolverine titles, the firm added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax partners with Saudi Arabia’s muvi Cinemas for four new laser locations
- Constellation Software to Release Q2 Results, Enhances Shareholder Engagement
- Imax price target raised to $30 from $27 at B. Riley
- Auxly Shareholders Approve All Resolutions
- Cineworld leaning towards British restructuring, Sky News reports